Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.
about
The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colonChronically Elevated Levels of Short-Chain Fatty Acids Induce T Cell-Mediated Ureteritis and Hydronephrosis.Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease?Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).Dietary polyphenols against metabolic disorders: How far have we progressed in the understanding of the molecular mechanisms of action of these compounds?Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses.Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes.Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.Nutrients, Infectious and Inflammatory Diseases.Neural FFA3 activation inversely regulates anion secretion evoked by nicotinic ACh receptor activation in rat proximal colon.Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.Regulation of Ion Transport in the Intestine by Free Fatty Acid Receptor 2 and 3: Possible Involvement of the Diffuse Chemosensory System.
P2860
Q35627470-2BDE63CD-97CA-4024-B17C-BD68FF095D2DQ35906622-2A450713-F925-4E83-A5CC-2CE5C7F39279Q37130920-5002DBEA-F723-4B83-AE8C-17F138AC6AD6Q38461139-3CF4EDC0-7B59-44DF-BC2A-1AC11D717402Q38521024-7B3C3FFC-D263-4F06-9E44-3F55D48E4C6FQ39393210-7A1C4B94-8A0C-4DB7-B645-C36AC3E2316CQ41071305-666A7C62-FB3A-4D0C-868A-72BB18EFEB4AQ41189607-2135D40E-A659-4A01-934A-58400B1FCC10Q41577330-92492F55-9AD6-4203-AABF-8D265253A5B5Q41984412-8925F17E-1096-4490-8163-F7C19F767970Q46159464-31E19B71-3CBD-4724-87F9-D7DC523A49C2Q48064520-2F806CD6-E313-4009-8BFA-18BB6DEB9608Q50193587-90D6D63E-B824-4982-86C6-02EE8AB42C4EQ52728485-01977BDA-8AE0-4D6B-B394-6F35DEB889A9
P2860
Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pathobiology and potential the ...... gut inflammation and obesity.
@ast
Pathobiology and potential the ...... gut inflammation and obesity.
@en
type
label
Pathobiology and potential the ...... gut inflammation and obesity.
@ast
Pathobiology and potential the ...... gut inflammation and obesity.
@en
prefLabel
Pathobiology and potential the ...... gut inflammation and obesity.
@ast
Pathobiology and potential the ...... gut inflammation and obesity.
@en
P2860
P1476
Pathobiology and potential the ...... gut inflammation and obesity.
@en
P2093
Jessica Soldavini
Jonathan D Kaunitz
P2860
P2888
P304
P356
10.1007/S10620-013-2744-4
P577
2013-07-10T00:00:00Z